Drug Pipeline

Pneumococcal 13-valent Conjugate Vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-22 NCT07600983 Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine… Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT03942328 Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With… Stage III Hepatocellular Carcinoma AJCC v8 Recruiting
NCT06647407 Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine… Meningococcal Immunization Active, Not Recruiting
NCT07600983 Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine… Streptococcus Pneumoniae Infection Not Yet Recruiting
Sponsors Running Pneumococcal 13-valent Conjugate Vaccine Trials
Mayo Clinic (1) Sanofi Pasteur, a Sanofi Company (1) CanSino Biologics Inc. (1)
Disease Areas
Liver Cancer (1) Cholangiocarcinoma (1)
Get alerts when Pneumococcal 13-valent Conjugate Vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free